Drug Shortage Report for SOLYSTAT
| Report ID | 241585 |
| Drug Identification Number | 00769541 |
| Brand name | SOLYSTAT |
| Common or Proper name | Solystat |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
| Strength(s) | 250MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 500 ml |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-09-23 |
| Estimated end date | 2024-11-25 |
| Actual end date | 2024-11-08 |
| Shortage status | Resolved |
| Updated date | 2024-11-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-11-09 | English | Compare |
| v4 | 2024-11-08 | French | Compare |
| v3 | 2024-11-08 | English | Compare |
| v2 | 2024-10-30 | French | Compare |
| v1 | 2024-10-30 | English | Compare |
Showing 1 to 5 of 5